mitoxantrone has been researched along with Adrenal Cortex Cancer in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rashed, WM | 1 |
Zekri, W | 1 |
Awad, M | 1 |
Taha, H | 1 |
Abdalla, B | 1 |
Alfaar, AS | 1 |
Mantzios, G | 1 |
Tsirigotis, P | 1 |
Veliou, F | 1 |
Boutsikakis, I | 1 |
Petraki, L | 1 |
Kolovos, J | 1 |
Papageorgiou, S | 1 |
Robos, Y | 1 |
1 review available for mitoxantrone and Adrenal Cortex Cancer
Article | Year |
---|---|
Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe | 2004 |
1 other study available for mitoxantrone and Adrenal Cortex Cancer
Article | Year |
---|---|
Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 2017 |